Abstract
Background
The role of early-life vitamin D in childhood allergy is controversial.
Objective
To assess vitamin D exposure in early life by multiple modalities and ascertain their association with childhood allergic rhinitis and allergic sensitization.
Methods
1248 mother-child pairs from a US prebirth cohort unselected for any disease were studied. Vitamin D exposure was assessed by measures of maternal intake during the first and second trimesters of pregnancy and serum vitamin D (25(OH)D) levels in mothers during pregnancy, cord blood, and in children at school age (median age 7.7 years, IQR 1.0 years). Tests for associations between vitamin D exposure with ever allergic rhinitis, serum total IgE, and allergen sensitization at school age were conducted.
Results
The correlations between maternal intake of vitamin D during pregnancy and serum 25(OH)D levels in pregnant mothers, cord blood, and children at school age were weak to moderate (r = −0.03 to 0.53). Each 100 IU/day of food-based vitamin D intake during the first and second trimesters (equivalent to the amount of vitamin D in an 8-ounce serving of milk) was associated with 21% and 20% reduced odds of ever allergic rhinitis at school age (OR 0.79 (95% CI 0.67–0.92) and OR 0.80 (95%CI 0.68–0.93), respectively). There were no associations between maternal supplemental vitamin D intake or serum 25(OH)D levels at any time point with ever allergic rhinitis. There were no associations between any vitamin D exposure and serum total IgE or allergen sensitization at school age.
Conclusions
Inclusion of foods containing vitamin D in maternal diets during pregnancy may have beneficial effects on childhood allergic rhinitis.
Keywords: Allergic rhinitis, vitamin D, atopy, prenatal, perinatal, childhood, sensitization, food, supplement, allergy
Introduction
The role of early life vitamin D exposure in the development of childhood allergy remains controversial. Vitamin D modulates both the innate and adaptive immune systems, with direct effects on B cells, T-cell activation and antigen presenting cells.1–3 Vitamin D deficiency may impair epithelial barrier integrity, leading to increased and inappropriate mucosal exposure to antigens and a pro-sensitization immune imbalance that compromises immunologic tolerance.1, 4 As such, vitamin D has been the focus of many studies examining its relationship with allergic disease. Because vitamin D may exert immunomodulatory effects in utero as early as the first trimester,1 prenatal vitamin D exposure should be considered when examining the potential effects of early-life vitamin D.
Some epidemiologic studies suggest a protective effect of higher vitamin D exposure in early life, while other results point to increased odds of childhood allergy or no associations with vitamin D exposure.1, 2 Differences in exposure assessment, outcome definitions, study population, and study design account for many of these disparate results. The majority of studies examining the relationship between vitamin D and allergy outcomes have assessed vitamin D at single time points, either via a one-time assessment of dietary intake or serum 25-hydroxyvitamin D (25(OH)D) level.1, 2 These singular measures of exposure each have their limitations. While vitamin D intake assessment (via food frequency questionnaire) reflects long-term diet,1 it does not account for sun exposure, another source of vitamin D in people. On the other hand, while 25(OH)D levels may reflect biologically available vitamin D, these levels fluctuate between measurements and season5 and do not capture circulating levels of other vitamin D metabolites.6 Distinct modalities of vitamin D assessment capture disparate dimensions of its biologic effects, and it is therefore unlikely that a single assessment of vitamin D status is sufficient to address whether vitamin D is associated with allergic disease.1, 2, 7
The hypothesis of this study was that early life vitamin D exposure is associated with allergic rhinitis at school age. This study sought to address the limitations of previous studies by examining early life vitamin D exposure in a well-characterized prebirth cohort via multiple modalities over time, including assessments of maternal vitamin D intake during the first and second trimesters of pregnancy and serum 25(OH)D levels during the prenatal, perinatal, and childhood periods. Allergic rhinitis was chosen as the primary outcome (with allergic sensitization as a secondary outcome), as few studies of vitamin D have focused on allergic rhinitis despite the high population prevalence of this disease.
Methods
Study design and subjects
Project Viva is a prospective, prebirth cohort study of participants recruited from Atrius Health, a large multispecialty practice in eastern Massachusetts. The goal of this longitudinal epidemiologic cohort was to study dietary factors that could influence health in early life. Participants were not selected for any disease. Study details have been previously described.8
Enrollment occurred between 1999 and 2002 for women with singleton pregnancy. In-person interviews and questionnaires were administered after the initial prenatal visit, at an average of 10 weeks of gestation, and at 26–28 weeks of gestation. Interviews and questionnaires on child health were administered at 6 months, 1 year, and annually thereafter. Outcome data for this study was collected between study inception and the school age in-person visit (median age 7.7 years, age range 6.6–10.9 years, IQR 1.0 years). Study protocols were approved by the institutional review boards of participating institutions. Of the 2128 children delivered in Project Viva, 1248 mother-child pairs who came to the school age in-person visit and responded to the questionnaire item regarding allergic rhinitis or had allergen sensitization measured were included in this study.
Maternal dietary and supplemental vitamin D intake assessment
Maternal dietary assessments at the first and second trimester visits were based on a validated 166-item semi-quantitative food frequency questionnaire (FFQ) modified for pregnancy9 that has been previously described10 and is fully available here: https://www.hms.harvard.edu/viva/Data-collection-forms/early-preg-ffq1.pdf. Food-based intake of vitamin D was calculated by summing the amount of vitamin D in foods in the FFQ containing vitamin D based on the Harvard nutrient composition database used for the Nurses’ Health Study and other large cohort studies.11 Supplement-based intake of vitamin D was calculated based on queried dose, duration, and brand/type of multivitamin, prescribed prenatal vitamin, and supplements by separate interview during the first trimester, and by self-completed questionnaire during the second trimester.10 Total vitamin D intake was the sum of vitamin D from food and supplement sources. Vitamin D intake was energy-adjusted using the nutrient residual method.12
Serum 25(OH)D assessment during the prenatal, perinatal, and childhood periods
Serum 25(OH)D levels were measured at three time points: in mothers during the second trimester of pregnancy, in cord blood at birth, and in children at school age. Each sample was analyzed in duplicate for 25(OH)D concentration, once using an automated chemiluminescence immunoassay,13 and once using a manual radioimmunoassay.14 As has been done in prior studies, two values were averaged to obtain more stable estimates of 25(OH)D level.15–17 For quality control, the laboratory used U.S. National Institutes of Standards and Technology level 1.
Childhood outcomes
Ever allergic rhinitis at school age was defined as positive if a mother answered yes to “Have you ever been told by a health care professional, such as a doctor, physician assistant or nurse practitioner, that your child has hay fever, seasonal allergies or allergic rhinitis (runny nose due to allergies)?” at the school age interview. This question was based on the questionnaire from the International Study of Asthma and Childhood.18 Maternal and paternal asthma, allergic rhinitis, and atopic dermatitis were each considered positive if a mother reported at week 10 of gestation that she or the child’s biological father had a history of the respective condition. Maternal allergy was considered positive if maternal asthma, allergic rhinitis, or atopic dermatitis was positive, and paternal allergy was defined analogously. Parental allergy was considered positive if maternal or paternal allergy was positive.
Of the 1248 children in the analysis sample, 702 had blood drawn at school age for additional studies, of which 616 children had sufficient sample to measure serum total IgE and allergen specific IgE (sIgE levels) by Phadia ImmunoCAP (Uppsala, Sweden). A variety of perennial and seasonal environmental allergens common to the United States Northeast were assessed, including Dermatophagoides farinae, Aspergillus fumigatus, Alternaria alternata, rye grass, ragweed, cat dander, dog dander, and Blattella germanica. Sensitization to environmental allergens was considered positive if the subject had an allergen specific IgE level ≥ 0.35 kU/L to any of the environmental allergens tested.
Statistical analyses
Spearman rank correlation was used to assess the pairwise correlation between measures of vitamin D. Unadjusted and multivariable adjusted logistic regression models were used to examine associations between vitamin D measures and ever allergic rhinitis at school age. For ease of interpretation, 100 IU of vitamin D (the amount of vitamin D in an 8 ounce glass of milk) was used as the unit of exposure for vitamin D intake, and 25 nmol/ml of serum 25(OH)D was used as the unit of exposure for serum measures of vitamin D. Models included as covariates factors that could confound the association of vitamin D with allergic rhinitis, including maternal education, maternal pre-pregnancy body mass index (BMI), smoking during pregnancy, parity at enrollment, parental allergy, and child sex, ethnicity, season of birth, breastfeeding history, and child BMI at school age. To explore potential bias related to follow up at school age, sensitivity analyses limited to subjects with school age 25(OH)D levels (n=652) were performed. In the 616 subjects for whom serum total IgE levels and environmental allergen sensitization status were available, association testing was performed for vitamin D and these intermediate phenotypes of allergy. All analyses were performed using R 2.15.2 (R Foundation for Statistical Computing, Vienna, Austria) and SAS 9.3 (SAS Institute, Cary, NC).
Results
Study population
The baseline characteristics of the participants are shown in Table 1. Compared to the 880 participants excluded, the 1248 participants with school age data included showed higher proportions of maternal Caucasian ethnicity (69% vs. 63%), maternal college or graduate education (69% vs. 58%), annual household income exceeding $70,000 (63% vs. 58%), and parental allergy (59% vs. 57%). Compared to the general US population,19 the study population contained a higher proportion of African Americans and lower proportion of Hispanics. The majority of mothers were college-educated and most households were not low income. Rates of parental asthma, allergic rhinitis, and atopic dermatitis were consistent with those for the general US population.20–22
Table 1.
Parental and child characteristics among participants from the Project Viva pre-birth cohort
| Characteristic | Participants with school age data (N=1248) | Participants with school age data AND sIgE levels measured (N=616) |
|---|---|---|
| Mean (SD) or N (%) | ||
| Parental Characteristics | ||
| Maternal education ≥ college graduate | 858 (69.1%) | 407 (66.5%) |
| Maternal smoking during pregnancy | 119 (9.6%) | 61 (9.9%) |
| Maternal pre-pregnancy BMI, kg/m2 | 24.7 (5.3) | 25.1 (5.3) |
| Maternal allergy | 492 (39.6%) | 241 (39.4%) |
| Maternal asthma | 157 (12.7%) | 84 (13.7%) |
| Maternal allergic rhinitis | 358 (28.8%) | 167 (27.3%) |
| Maternal atopic dermatitis | 162 (13.0%) | 72 (11.8%) |
| Paternal allergy | 425 (34.7%) | 200 (33.2%) |
| Paternal asthma | 145 (12.0%) | 71 (12.0%) |
| Paternal allergic rhinitis | 318 (26.8%) | 154 (26.5%) |
| Paternal atopic dermatitis | 74 (6.1%) | 29 (4.9%) |
| Household income ≥ $70,000 | 718 (63.3%) | 359 (64.2%) |
| Parity at enrollment | 0.74 (0.89) | 0.86 (0.95) |
| Child characteristics | ||
| Sex- female | 619 (49.6%) | 302 (49.0%) |
| Season of birth | ||
| Fall | 267 (21.4%) | 142 (23.1%) |
| Winter | 322 (25.8%) | 155 (25.2%) |
| Spring | 324 (26.0%) | 154 (25.0%) |
| Summer | 335 (26.8%) | 165 (26.8%) |
| Ethnicity | ||
| Caucasian | 810 (65.0%) | 383 (62.4%) |
| African American | 198 (15.9%) | 121 (19.7%) |
| Hispanic | 51 (4.1%) | 30 (4.9%) |
| Asian | 40 (3.2%) | 13 (2.1%) |
| >1 race or other | 147 (11.8%) | 67 (10.9%) |
| Breastfed ≥ 6 months | 649 (55.9%) | 319 (55.5%) |
| Age at school age visit, years | 7.9 (0.8) | 7.8 (0.7) |
| BMI at school age, kg/m2 | 17.3 (3.1) | 17.3 (3.3) |
| Maternal Vitamin D intake during pregnancy* | ||
| First trimester | ||
| Food – IU/day | 218.1 (112.0) | 218.5 (114.8) |
| Supplement –IU/day | 282.1 (173.7) | 274.5 (178.3) |
| Total –IU/day | 500.1 (207.6) | 493.0 (215.8) |
| Second trimester | ||
| Food – IU/day | 231.6 (112.0) | 232.7 (115.9) |
| Supplement – IU/day | 369.3 (142.3) | 367.5 (147.1) |
| Total –IU/day | 600.9 (184.3) | 600.2 (189.5) |
| Serum vitamin D (25(OH)D) levels | ||
| Maternal, second trimester – nmol/L | 59.0 (21.4) | 59.6 (21.9) |
| Cord blood– nmol/L | 46.4 (18.0) | 45.8 (18.1) |
| Child at school age– nmol/L | 67.5 (19.1) | 67.4 (19.1) |
| Child sensitization and allergic rhinitis | ||
| Total IgE – kU/L | 48.5 (2–3284)** | |
| Environmental allergen | 259 (42.0%) | |
| sensitization | ||
| Allergic rhinitis | 291 (23.4%) | 145 (23.8%) |
energy adjusted nutrients using the nutrient residual method.
geometric mean (range) provided
Maternal intake of vitamin D by food, supplement, and all sources was higher during the second trimester than the first trimester (Table 1). Serum 25(OH)D levels were < 50 nmol/L (“deficient” per Endocrine Society guidelines23) in 33% of mothers during the second trimester, 61% of infants, and 18% of children at school age. Of note, norms for cord blood 25(OH)D are not well-established, and guidelines for adult serum 25(OH)D are typically applied.23
Among the 616 children in with IgE levels, serum total IgE levels ranged from 2 to 3284 kU/L with a geometric mean level of 48.5 kU/L (Table 1). 42% of children were sensitized to at least one of the 8 environmental allergens tested at school age. The prevalence of ever allergic rhinitis at school age (23.8%) was consistent with the 10–30% prevalence of allergic rhinitis reported for Americans.21
Weak to moderate correlations between pairs of vitamin D measures
There was moderate correlation between total maternal vitamin D intake during the first and second trimesters (r=0.38), and relatively low correlation between these intake measures and maternal, cord blood, and childhood serum 25(OH)D levels (Figure 1A). Maternal serum 25(OH)D levels modestly correlated with cord blood levels (r=0.53), and cord blood levels modestly correlated with childhood serum levels (r=0.46), but maternal and child levels were not well correlated (r=0.29).
Figure 1. Correlation between vitamin D measures obtained during the prenatal, perinatal, and childhood periods in Project Viva participants.
A: Spearman rank correlation coefficients are shown for tests of correlation between total maternal vitamin D intake during the first and second trimesters, maternal serum 25(OH)D level during the second trimester, cord blood 25(OH)D level, and child serum 25(OH)D level at school age. B: Spearman rank correlation coefficients are shown for tests of correlation between maternal intake of vitamin D analyzed by source, including food, supplemental, and total intakes during the first and second trimesters. Color scale and eccentricity of the shapes correspond to numerical values of Spearman rank correlation coefficients. All Spearman rank correlation coefficients in this figure were statistically significant (at P value ranging from < 2.2 × 10−16 to 0.0009), except for the three correlation coefficients marked with *.
Comparisons of the mode of maternal vitamin D intake during the first and second trimesters showed no significant correlation between vitamin D intake by food and by supplement during the first trimester, and low correlation during the second trimester (r=0.10) (Figure 1B). Intake of vitamin D by food sources was moderately correlated between the first and second trimesters (r=0.54), while intake of supplemental vitamin D weakly correlated between the first and second trimesters (r=0.28).
Food-based vitamin D intake during pregnancy is associated with reduced odds of ever allergic rhinitis at school age
Each additional 100 IU of maternal intake of food-based vitamin D (the amount of vitamin D contained in an 8-ounce glass of milk) during the first trimester was associated with a 21% reduced odds of ever allergic rhinitis at school age in our adjusted model (OR 0.79, 95%CI 0.67–0.92) (Figure 2). Similarly, each additional 100IU of maternal intake of food-based vitamin D during the second trimester was associated with a 20% reduced odds of ever allergic rhinitis at school age (OR 0.80, 95%CI 0.68–0.93). There were no associations between maternal intake of supplemental vitamin D and ever allergic rhinitis at school age (OR 1.00, 95%CI 0.91–1.10 for first trimester supplemental intake, and OR 0.98, 95%CI 0.88–1.10 for second trimester supplemental intake). Adjusted models also did not show associations between serum 25(OH)D levels measured during the second trimester in mothers, in cord blood, and at school age in children with allergic rhinitis by school age.
Figure 2. Associations between vitamin D measures (obtained during the prenatal, perinatal, and childhood periods) and ever allergic rhinitis at school age.
The unit of exposure for intake was 100IU/day (the amount of vitamin D contained in an 8 ounce serving of milk) and the unit for serum 25(OH)D level was 25 nmol/L. Models were adjusted for potential confounders, including maternal education, pre-pregnancy BMI, smoking during pregnancy, parity at enrollment, parental allergy, and child sex, ethnicity, season of birth, breastfeeding history, and BMI at school age. A forest plot is shown for results from the adjusted models.
Similarly, sensitivity analyses constrained to subjects with school age 25(OH)D levels (n=652) showed that maternal intake of food-based vitamin D during the first and second trimesters were associated with 21–22% reduced odds of ever allergic rhinitis at school age (Supplementary Table S1), with no associations between maternal supplemental or total vitamin D intake and this outcome. In this subset, maternal 25(OH)D during the second trimester was associated with 27% reduced odds of ever allergic rhinitis at school age. There were no associations between cord blood or school age 25(OH)D levels and allergic rhinitis.
No association between vitamin D and serum total IgE or environmental allergen sensitization
There were no associations between maternal vitamin D intake (food-based, supplemental, or total) and serum total IgE at school age (Supplementary Figure 1A). There were also no associations between any of the serum 25(OH)D levels (second trimester in mothers, in cord blood, and at school age in children) and serum total IgE at school age (Supplementary Figure 1B). Likewise, the adjusted models did not show associations between vitamin D measures and sensitization to environmental allergens (Figure 3).
Figure 3. Associations between vitamin D measures (obtained during the prenatal, perinatal, and childhood periods) and environmental allergen sensitization at school age.
The unit of exposure for intake was 100IU/day (the amount of vitamin D contained in an 8 ounce serving of milk) and the unit for serum 25(OH)D level was 25 nmol/L. Environmental allergen sensitization was based on allergen specific IgE level ≥ 0.35 kU/L to any of the environmental allergens tested. Models were adjusted for potential confounders, including maternal education, pre-pregnancy BMI, smoking during pregnancy, parity at enrollment, parental allergy, and child sex, ethnicity, season of birth, breastfeeding history, and BMI at school age. A forest plot is shown for results from the adjusted models.
Discussion
Main findings
We found that higher maternal intake of food-based vitamin D during the first and second trimesters of pregnancy was associated with ~20% lower risk of ever allergic rhinitis at school age. A protective association between vitamin D and childhood allergic rhinitis was not seen with prenatal intake of supplemental vitamin D or with serum 25(OH)D levels in mothers during pregnancy, during the perinatal period (cord blood), or in children during school age.
A major strength of this study is that vitamin D exposure in this prospective prebirth cohort was multiply assessed by two methods (intake and serum 25(OH)D level) and at three time points (prenatal, perinatal, and childhood). Many studies examining the relationship between vitamin D and allergy have examined vitamin D intake or serum level individually, and typically at single time points.1, 2
This study’s finding of an association between food-based (but not supplemental) vitamin D intake and reduced odds of ever allergic rhinitis at school age may be due to biologically available forms of vitamin D that are present in foods but not in supplements. Unmetabolized forms of vitamin D include cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2).7 These must be activated into the hormone 1,25(OH)2D for vitamin D to function in the body, or are converted to 25(OH)D, the storage form.24 Vitamin D intake (by food and/or supplement) is quantified by estimating intake of unmetabolized vitamin D (e.g. combining vitamin D2 and vitamin D3 intake). This approach may reasonably reflect the vitamin D content of supplements, which are typically vitamin D2 and D3, as well as the vitamin D content of foods that are fortified with vitamin D2 and D3 (e.g. milk, breakfast foods, orange juice). However, foods from animal sources that naturally contain vitamin D (e.g. all types of meats) also contain 25(OH)D. 25(OH)D is not currently accounted for in usual measures of food-based vitamin D intake. Not accounting for 25(OH)D naturally present in animal-based foods is problematic, because the presence of this metabolite raises the vitamin D content of these particular foods.7 Indeed, a recent study examining USDA data showed that accounting for the 25(OH)D content of animal-based foods reduced discrepancies between vitamin D intake and serum 25(OH)D levels.7 It is therefore possible that this study found significant associations with food-based vitamin D intake because intake measures covaried with additional 25(OH)D in these foods.
The study’s finding of a protective effect of maternal vitamin D intake from food sources but not from supplemental vitamin D intake or 25(OH)D levels may also be due to nutrients that accompany vitamin D in vitamin D-containing foods. These nutrients may reduce the odds of allergic rhinitis either directly or in synergy with vitamin D. Many studies in nutritional epidemiology have focused on specific nutrients and their association with asthma and allergy outcomes, with unresolved questions about whether individual nutrients are responsible for the associations observed, or whether they are markers of other nutrients or overall dietary pattern.25, 26 Foods are a rich mixture of many nutrients, and consistent with the concept of “food synergy” 26, there may be interactive effects on allergic diathesis between vitamin D and other nutrients in vitamin D-containing foods. This study’s finding of a protective effect of vitamin D from food sources could be because the vitamin D content of vitamin D-containing foods is a marker of the beneficial food synergy in these foods.
Comparison with other studies
Consistent with this study, Erkkola and colleagues reported an inverse relationship between maternal food-based intake of vitamin D during late pregnancy and allergic rhinitis in 5-year-old children. The subjects of this Finnish cohort had HLA-DQB1-conferred susceptibility for Type 1 diabetes.27 A relative strength of our study is that subjects were unselected for any disease or condition, which supports the generalizability of this study’s findings. An additional relative strength of our study is minimal recall bias-- mothers completed FFQs during the first and second trimesters, before any outcomes in their children occurred. In contrast, Erkkola et al. retrospectively assessed food intake during pregnancy by asking mothers of these diabetes susceptible children after delivery to recall their diet during the eighth month of pregnancy. Additionally, our examination of maternal intake of vitamin D occurred at two points during pregnancy. Maternal diet changes during pregnancy,10, 28 and this is particularly important to consider when examining vitamin D because maternal intake of vitamin D-rich foods varies between trimesters. For example, intake of skim or reduced fat dairy foods increases by 22%, of whole dairy foods by 15%, and of red and processed meats by 11% between the first and second trimesters of pregnancy.10 In our study, the inverse association between food-based vitamin D intake and ever allergic rhinitis at school age was present during both the first and second trimesters.
In contrast to this study’s findings and those of Erkkola et al., Maslova et al. found no association between vitamin D intake during the second trimester and childhood allergic rhinitis at age 7 years in the Danish Birth Cohort Study.5 Mothers in our study had higher levels of vitamin D exposure than those in the Danish study-- the median second trimester vitamin D intake by mothers in our prebirth cohort was 31% higher, with 80% higher median food-based intake and 19% higher median supplemental intake. The relatively higher vitamin D exposures in our study may have enabled detection of associations between maternal vitamin D intake and childhood allergic rhinitis.
We had hypothesized that there would be an association between vitamin D exposure and allergic rhinitis because a growing body of literature supports that vitamin D has immunomodulatory functions relevant to allergic disease.1–3 However, it was unclear from prior studies which mode of vitamin D exposure in early life would have greatest effect. This study’s results support that maternal food-based vitamin D intake during the first and second trimesters of pregnancy are exposures of high interest. This is consistent with the fact that early pregnancy is a formative period of fetal immune system development, with early forms of many cells involved in allergy developing and potentially influenced during this period. For example, during the first trimester, early dendritic and macrophage cells develop, positive and negative T cell selection occurs, immunoglobulin isotypes develop, and IgE production begins.1–3 As maternal vitamin D is bioavailable to the fetus during this time,1 maternal intake of vitamin D during early pregnancy could modulate the fetal immune system toward or away from allergic disorders in childhood.
Null findings
Although higher maternal intake of food-based vitamin D during pregnancy was associated with lower odds of ever allergic rhinitis at school age, there were no associations between serum 25(OH)D levels and this outcome (Figure 2). This was the case whether the serum level was assayed from mothers during the second trimester, cord blood, or the children at school age. Previous studies examining maternal,29 cord blood30–32 or childhood serum levels of 25(OH)D33–35 in many different populations (Danish, Australian, German, and Asian) have similarly reported no association with allergic rhinitis. The distinct association between vitamin D intake (as compared to serum 25(OH)D levels) with the development in allergic rhinitis may be because 25(OH)D levels fluctuate between measurement and season5, while vitamin D intake assessment (via food frequency questionnaire) reflects long-term diet and may be a more accurate measure of vitamin D exposure.1
Although there was an inverse association between maternal intake of food-based vitamin D during pregnancy with ever allergic rhinitis at school age, there was no association between vitamin D by any measure and serum total IgE or environmental allergen sensitization (Supplementary Figure 1, Figure 3). As environmental allergen sensitization and serum total IgE are intermediate phenotypes of allergic rhinitis and allergy, it may seem counterintuitive that vitamin D intake was not also associated with these outcomes, but these null findings can be explained in several ways. First, allergic rhinitis results from environmental allergen sensitization that leads to naso-ocular symptoms upon exposure to the corresponding allergen.36 But environmental sensitization may not necessarily lead to symptoms of allergic rhinitis, so these outcomes are never in complete agreement. Indeed, in the 616 children who had serum total and allergen specific IgE levels measured in the cohort, 26% were sensitized to an environmental allergen but did not report allergic rhinitis. Vitamin D intake may be associated with risk for sensitization that leads to an allergic phenotype, but not with sensitization only. Second, environmental sensitization was based on allergen specific IgE levels to 8 common indoor and outdoor environmental allergens. The inclusion of more environmental allergens in our sensitization assessment may have changed the outcome. Third, tests for association between vitamin D and allergen sensitization were restricted to the 616 children for whom serum total and allergen-specific IgE levels were available, while the full school age cohort (n=1277) was used for the primary analysis of allergic rhinitis. That said, a previous study examining 18,224 subjects similarly found no association between serum 25(OH)D levels and allergen sensitization, and power was not likely a limitation in that large study.37 As context, results of studies examining the relationship between early-life vitamin D exposure and serum IgE levels have been very inconsistent, with studies showing inverse,38–40 non-linear,30 and null31, 37, 41, 42 relationships.
Limitations
In an effort to address the limitations of previous studies, where single measures of vitamin D exposure were typically employed, 1, 2, 7 vitamin D exposure was measured by two methods (food intake questionnaire and serum 25(OH)D level) and at three time intervals (prenatal, perinatal, school age) in this study. Our focus on multiple exposures may raise concern regarding multiple testing, but this is strongly counterbalanced by the benefit of having multiple measures of vitamin D in a single cohort, as single measures of vitamin D exposure incompletely capture its potential effects.1, 2, 7
Conclusions
In conclusion, we performed a multifaceted assessment of vitamin D exposure during early life in a prebirth cohort of mothers and children unselected for any disease. Weak to moderate correlations between maternal vitamin D intake during pregnancy and serum 25(OH)D levels during the prenatal, perinatal, and childhood periods were observed. Food-based, but not supplemental, vitamin D intake by mothers during the first and second trimesters was associated with 20% reduced odds of ever allergic rhinitis at school age. There were no associations between any other measure of vitamin D and allergic rhinitis; likewise, all measures of vitamin D were not associated with serum total IgE level or environmental allergen sensitization at school age. This study’s results provide further motivation for randomized trials examining vitamin D intake during pregnancy and their effects on childhood asthma and allergy.
Supplementary Material
Key Messages.
Higher maternal intake of food-based vitamin D during pregnancy was associated with reduced odds of ever allergic rhinitis at school age.
Supplemental vitamin D intake and serum 25(OH)D levels during the prenatal, perinatal, or childhood periods) were not associated with ever allergic rhinitis at school age.
Inclusion of foods containing vitamin D in maternal diets during pregnancy may have beneficial effects on childhood allergic rhinitis.
Acknowledgments
Funding/Support: This study was supported by the National Institutes of Health (NIH AI093538, AI118833, HL61907, HL64925, HD34568, AI35786, HL68041, and HL007427)
Abbreviations/Acronyms
- 25(OH)D
serum 25-hydroxyvitamin D
- FFQ
Food frequency questionnaire
- sIgE
specific IgE
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Mirzakhani H, Al-Garawi A, Weiss ST, Litonjua AA. Vitamin D and the development of allergic disease: how important is it? Clin Exp Allergy. 2015;45:114–25. doi: 10.1111/cea.12430. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bacharier LB. Vitamin D status at birth: an important and potentially modifiable determinant of atopic disease in childhood? J Allergy Clin Immunol. 2014;133:154–5. doi: 10.1016/j.jaci.2013.07.034. [DOI] [PubMed] [Google Scholar]
- 3.Muehleisen B, Gallo RL. Vitamin D in allergic disease: shedding light on a complex problem. J Allergy Clin Immunol. 2013;131:324–9. doi: 10.1016/j.jaci.2012.12.1562. [DOI] [PubMed] [Google Scholar]
- 4.Hata TR, Kotol P, Jackson M, Nguyen M, Paik A, Udall D, et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol. 2008;122:829–31. doi: 10.1016/j.jaci.2008.08.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Maslova E, Hansen S, Jensen CB, Thorne-Lyman AL, Strom M, Olsen SF. Vitamin D intake in mid-pregnancy and child allergic disease - a prospective study in 44,825 Danish mother-child pairs. BMC Pregnancy Childbirth. 2013;13:199. doi: 10.1186/1471-2393-13-199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hollis BW, Wagner CL. Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab. 2013;98:4619–28. doi: 10.1210/jc.2013-2653. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Taylor CL, Patterson KY, Roseland JM, Wise SA, Merkel JM, Pehrsson PR, et al. Including food 25-hydroxyvitamin D in intake estimates may reduce the discrepancy between dietary and serum measures of vitamin D status. J Nutr. 2014;144:654–9. doi: 10.3945/jn.113.189811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Oken E, Kleinman KP, Berland WE, Simon SR, Rich-Edwards JW, Gillman MW. Decline in fish consumption among pregnant women after a national mercury advisory. Obstet Gynecol. 2003;102:346–51. doi: 10.1016/S0029-7844(03)00484-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fawzi WW, Rifas-Shiman SL, Rich-Edwards JW, Willett WC, Gillman MW. Calibration of a semi-quantitative food frequency questionnaire in early pregnancy. Ann Epidemiol. 2004;14:754–62. doi: 10.1016/j.annepidem.2004.03.001. [DOI] [PubMed] [Google Scholar]
- 10.Rifas-Shiman SL, Rich-Edwards JW, Willett WC, Kleinman KP, Oken E, Gillman MW. Changes in dietary intake from the first to the second trimester of pregnancy. Paediatr Perinat Epidemiol. 2006;20:35–42. doi: 10.1111/j.1365-3016.2006.00691.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491–9. doi: 10.1056/NEJM199711203372102. [DOI] [PubMed] [Google Scholar]
- 12.Willett W. Nutritional Epidemiology. New York: Oxford University Press; 2013. [Google Scholar]
- 13.Ersfeld DL, Rao DS, Body JJ, Sackrison JL, Jr, Miller AB, Parikh N, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem. 2004;37:867–74. doi: 10.1016/j.clinbiochem.2004.06.006. [DOI] [PubMed] [Google Scholar]
- 14.Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem. 1993;39:529–33. [PubMed] [Google Scholar]
- 15.Burris HH, Rifas-Shiman SL, Kleinman K, Litonjua AA, Huh SY, Rich-Edwards JW, et al. Vitamin D deficiency in pregnancy and gestational diabetes mellitus. Am J Obstet Gynecol. 2012;207:182, e1–8. doi: 10.1016/j.ajog.2012.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Burris HH, Rifas-Shiman SL, Camargo CA, Jr, Litonjua AA, Huh SY, Rich-Edwards JW, et al. Plasma 25-hydroxyvitamin D during pregnancy and small-for-gestational age in black and white infants. Ann Epidemiol. 2012;22:581–6. doi: 10.1016/j.annepidem.2012.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Burris HH, Rifas-Shiman SL, Huh SY, Kleinman K, Litonjua AA, Oken E, et al. Vitamin D status and hypertensive disorders in pregnancy. Ann Epidemiol. 2014;24:399–403. e1. doi: 10.1016/j.annepidem.2014.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8:483–91. doi: 10.1183/09031936.95.08030483. [DOI] [PubMed] [Google Scholar]
- 19.Bureau USC. Current Population Survey. U.S. Department of Commerce; 2013. http://www.census.gov/hhes/www/cpstables/032012/hhinc/hinc01_000.htm, downloaded May 1, 2013. [Google Scholar]
- 20.Control CfD. Lifetime Asthma Prevalence Percents by Age, United States. [accessed 11/12/3];2011 National Health Interview Survey (NHIS) Data. 2011 http://www.cdc.gov/asthma/nhis/2011/table2-1.htm.
- 21.Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122:S1–84. doi: 10.1016/j.jaci.2008.06.003. [DOI] [PubMed] [Google Scholar]
- 22.Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131:67–73. doi: 10.1038/jid.2010.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30. doi: 10.1210/jc.2011-0385. [DOI] [PubMed] [Google Scholar]
- 24.Vitamin D: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements; 2014. downloaded from http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ on 1/28/2015. [Google Scholar]
- 25.Tricon S, Willers S, Smit HA, Burney PG, Devereux G, Frew AJ, Halken S, Høst A, Nelson M, Shaheen S, Warner JO, Calder PC. Nutrition and allergic disease. Clinical & Experimental Allergy Reviews. 2006;6:117–88. [Google Scholar]
- 26.Jacobs DR, Tapsell LC. Food synergy: the key to a healthy diet. Proc Nutr Soc. 2013;72:200–6. doi: 10.1017/S0029665112003011. [DOI] [PubMed] [Google Scholar]
- 27.Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Ahonen S, Nevalainen J, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39:875–82. doi: 10.1111/j.1365-2222.2009.03234.x. [DOI] [PubMed] [Google Scholar]
- 28.Rogers I, Emmett P. Diet during pregnancy in a population of pregnant women in South West England. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Eur J Clin Nutr. 1998;52:246–50. doi: 10.1038/sj.ejcn.1600543. [DOI] [PubMed] [Google Scholar]
- 29.Maslova E, Hansen S, Thorne-Lyman AL, Jensen CB, Strom M, Cohen A, et al. Predicted vitamin D status in mid-pregnancy and child allergic disease. Pediatr Allergy Immunol. 2014;25:706–13. doi: 10.1111/pai.12295. [DOI] [PubMed] [Google Scholar]
- 30.Rothers J, Wright AL, Stern DA, Halonen M, Camargo CA., Jr Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J Allergy Clin Immunol. 2011;128:1093–9. e1–5. doi: 10.1016/j.jaci.2011.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chawes BL, Bonnelykke K, Jensen PF, Schoos AM, Heickendorff L, Bisgaard H. Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study. PLoS One. 2014;9:e99856. doi: 10.1371/journal.pone.0099856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Baiz N, Dargent-Molina P, Wark JD, Souberbielle JC, Annesi-Maesano I Group EM-CCS. Cord serum 25-hydroxyvitamin D and risk of early childhood transient wheezing and atopic dermatitis. J Allergy Clin Immunol. 2014;133:147–53. doi: 10.1016/j.jaci.2013.05.017. [DOI] [PubMed] [Google Scholar]
- 33.Hollams EM, Hart PH, Holt BJ, Serralha M, Parsons F, de Klerk NH, et al. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Respir J. 2011;38:1320–7. doi: 10.1183/09031936.00029011. [DOI] [PubMed] [Google Scholar]
- 34.Wawro N, Heinrich J, Thiering E, Kratzsch J, Schaaf B, Hoffmann B, et al. Serum 25(OH)D concentrations and atopic diseases at age 10: results from the GINIplus and LISAplus birth cohort studies. BMC Pediatr. 2014;14:286. doi: 10.1186/s12887-014-0286-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Yao TC, Tu YL, Chang SW, Tsai HJ, Gu PW, Ning HC, et al. Suboptimal vitamin D status in a population-based study of Asian children: prevalence and relation to allergic diseases and atopy. PLoS One. 2014;9:e99105. doi: 10.1371/journal.pone.0099105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy. 2008;63:8–160. doi: 10.1111/j.1398-9995.2007.01620.x. [DOI] [PubMed] [Google Scholar]
- 37.Wjst M, Hypponen E. Vitamin D serum levels and allergic rhinitis. Allergy. 2007;62:1085–6. doi: 10.1111/j.1398-9995.2007.01437.x. [DOI] [PubMed] [Google Scholar]
- 38.Sharief S, Jariwala S, Kumar J, Muntner P, Melamed ML. Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol. 2011;127:1195–202. doi: 10.1016/j.jaci.2011.01.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009;179:765–71. doi: 10.1164/rccm.200808-1361OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125:995–1000. doi: 10.1016/j.jaci.2010.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Cheng HM, Kim S, Park GH, Chang SE, Bang S, Won CH, et al. Low vitamin D levels are associated with atopic dermatitis, but not allergic rhinitis, asthma, or IgE sensitization, in the adult Korean population. J Allergy Clin Immunol. 2014;133:1048–55. doi: 10.1016/j.jaci.2013.10.055. [DOI] [PubMed] [Google Scholar]
- 42.Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126:52–8. e5. doi: 10.1016/j.jaci.2010.03.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



